Tyrosine Hydroxylase Neurons Regulate Growth Hormone Secretion via Short-Loop Negative Feedback

Classical studies suggest that growth hormone (GH) secretion is controlled by negative-feedback loops mediated by GH-releasing hormone (GHRH)- or somatostatin-expressing neurons. Catecholamines are known to alter GH secretion and neurons expressing TH are located in several brain areas containing GH-responsive cells. However, whether TH-expressing neurons are required to regulate GH secretion via negative-feedback mechanisms is unknown. In the present study, we showed that between 50% and 90% of TH-expressing neurons in the periventricular, paraventricular, and arcuate hypothalamic nuclei and locus ceruleus of mice exhibited STAT5 phosphorylation (pSTAT5) after an acute GH injection. Ablation of GH receptor (GHR) from TH cells or in the entire brain markedly increased GH pulse secretion and body growth in both male and female mice. In contrast, GHR ablation in cells that express the dopamine transporter (DAT) or dopamine β-hydroxylase (DBH; marker of noradrenergic/adrenergic cells) did not affect body growth. Nevertheless, less than 50% of TH-expressing neurons in the hypothalamus were found to express DAT. Ablation of GHR in TH cells increased the hypothalamic expression of Ghrh mRNA, although very few GHRH neurons were found to coexpress TH- and GH-induced pSTAT5. In summary, TH neurons that do not express DAT or DBH are required for the autoregulation of GH secretion via a negative-feedback loop. Our findings revealed a critical and previously unidentified group of catecholaminergic interneurons that are apt to sense changes in GH levels and regulate the somatotropic axis in mice. SIGNIFICANCE STATEMENT Textbooks indicate until now that the pulsatile pattern of growth hormone (GH) secretion is primarily controlled by GH-releasing hormone and somatostatin neurons. The regulation of GH secretion relies on the ability of these cells to sense changes in circulating GH levels to adjust pituitary GH secretion within a narrow physiological range. However, our study identifies a specific population of tyrosine hydroxylase-expressing neurons that is critical to autoregulate GH secretion via a negative-feedback loop. The lack of this mechanism in transgenic mice results in aberrant GH secretion and body growth. Since GH plays a key role in cell proliferation, body growth, and metabolism, our findings provide a major advance to understand how the brain regulates the somatotropic axis.

[1]  J. Kopchick,et al.  Central growth hormone action regulates metabolism during pregnancy. , 2019, American journal of physiology. Endocrinology and metabolism.

[2]  J. Kopchick,et al.  Central growth hormone signaling is not required for the timing of puberty. , 2019, The Journal of endocrinology.

[3]  M. Metzger,et al.  Growth hormone regulates neuroendocrine responses to weight loss via AgRP neurons , 2019, Nature Communications.

[4]  B. Hyland,et al.  Incomplete concordance of dopamine transporter Cre (DATIREScre)-mediated recombination and tyrosine hydroxylase immunoreactivity in the mouse forebrain , 2018, Journal of Chemical Neuroanatomy.

[5]  Alan C. Rupp,et al.  Specific subpopulations of hypothalamic leptin receptor-expressing neurons mediate the effects of early developmental leptin receptor deletion on energy balance , 2018, Molecular metabolism.

[6]  M. Ugrumov,et al.  Cooperative synthesis of dopamine in rat mediobasal hypothalamus as a compensatory mechanism in hyperprolactinemia , 2017, Biochemistry (Moscow).

[7]  Evan Z. Macosko,et al.  A Molecular Census of Arcuate Hypothalamus and Median Eminence Cell Types , 2017, Nature Neuroscience.

[8]  S. Melmed,et al.  Somatostatin and dopamine receptor regulation of pituitary somatotroph adenomas , 2017, Pituitary.

[9]  D. Grattan,et al.  Conditional Deletion of the Prolactin Receptor Reveals Functional Subpopulations of Dopamine Neurons in the Arcuate Nucleus of the Hypothalamus , 2016, The Journal of Neuroscience.

[10]  C. Chen,et al.  Neuroendocrine Regulation of Growth Hormone Secretion. , 2016, Comprehensive Physiology.

[11]  M. Metzger,et al.  Distribution of growth hormone-responsive cells in the mouse brain , 2016, Brain Structure and Function.

[12]  M. Tschöp,et al.  Effect of Deletion of Ghrelin‐O‐Acyltransferase on the Pulsatile Release of Growth Hormone in Mice , 2015, Journal of neuroendocrinology.

[13]  M. Low,et al.  Central Dopamine D2 Receptors Regulate Growth-Hormone-Dependent Body Growth and Pheromone Signaling to Conspecific Males , 2013, The Journal of Neuroscience.

[14]  A. Bartke,et al.  The role of GH in adipose tissue: lessons from adipose-specific GH receptor gene-disrupted mice. , 2013, Molecular endocrinology.

[15]  J. Veldhuis,et al.  The decline in pulsatile GH secretion throughout early adulthood in mice is exacerbated by dietary-induced weight gain. , 2012, Endocrinology.

[16]  Frédérique Clément,et al.  DynPeak: An Algorithm for Pulse Detection and Frequency Analysis in Hormonal Time Series , 2011, PloS one.

[17]  C. Kahn,et al.  Elevated GH/IGF-I, due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner. , 2011, Endocrinology.

[18]  M. Waters,et al.  Development of a method for the determination of pulsatile growth hormone secretion in mice. , 2011, Endocrinology.

[19]  T. Clemens,et al.  Liver-specific Deletion of the Growth Hormone Receptor Reveals Essential Role of Growth Hormone Signaling in Hepatic Lipid Metabolism*♦ , 2009, The Journal of Biological Chemistry.

[20]  M. Thorner,et al.  Evidence for acyl-ghrelin modulation of growth hormone release in the fed state. , 2008, The Journal of clinical endocrinology and metabolism.

[21]  F. Tronche,et al.  Analysis of dopamine transporter gene expression pattern − generation of DAT‐iCre transgenic mice , 2007, The FEBS journal.

[22]  R. Parlato,et al.  Specific ablation of the transcription factor CREB in sympathetic neurons surprisingly protects against developmentally regulated apoptosis , 2007, Development.

[23]  I. Robinson,et al.  Multiple co-localizations in arcuate GHRH-eGFP neurons in the mouse hypothalamus , 2007, Journal of Chemical Neuroanatomy.

[24]  J. Epelbaum,et al.  Anatomy of the Hypophysiotropic Somatostatinergic and Growth Hormone-releasing Hormone System Minireview , 2006, Neurochemical Research.

[25]  I. Clarke,et al.  Noradrenergic Regulation of Hypothalamic Cells that Produce Growth Hormone‐Releasing Hormone and Somatostatin and the Effect of Altered Adiposity in Sheep , 2005, Journal of neuroendocrinology.

[26]  C. Phelps,et al.  Growth Hormone‐Releasing Hormone‐Producing and Dopaminergic Neurones in the Mouse Arcuate Nucleus Are Independently Regulated Populations , 2003, Journal of neuroendocrinology.

[27]  A. Calas,et al.  Tyrosine hydroxylase- and/or aromatic L-amino acid decarboxylase-expressing neurons in the rat arcuate nucleus: ontogenesis and functional significance , 2002, Psychoneuroendocrinology.

[28]  C. Feierstein,et al.  Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. , 2002, Endocrinology.

[29]  R. Paylor,et al.  Impairment in motor learning of somatostatin null mutant mice , 2001, Brain Research.

[30]  A. Barkan,et al.  Aging-related growth hormone (GH) decrease is a selective hypothalamic GH-releasing hormone pulse amplitude mediated phenomenon. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[31]  E. Bissonette,et al.  Intracerebroventricular Administration of the Rat Growth Hormone (GH) Receptor Antagonist G118R Stimulates GH Secretion: Evidence for the Existence of Short Loop Negative Feedback of GH , 2000, Journal of neuroendocrinology.

[32]  P. Iglesias,et al.  Current management of acromegaly , 2000, Expert opinion on pharmacotherapy.

[33]  M. Peruggia,et al.  High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary. , 2000, Endocrinology.

[34]  A. Giustina,et al.  Neuroendocrine Regulation of Growth Hormone Secretion , 2000 .

[35]  S. Caplan,et al.  Genesis of the ultradian rhythm of GH secretion: a new model unifying experimental observations in rats. , 1998, The American journal of physiology.

[36]  K. Krueger,et al.  Regulatory mechanisms of growth hormone secretion are sexually dimorphic. , 1998, The Journal of clinical investigation.

[37]  J. Kamegai,et al.  Growth hormone inhibits its own secretion by acting on the hypothalamus through its receptors on neuropeptide Y neurons in the arcuate nucleus and somatostatin neurons in the periventricular nucleus. , 1998, Endocrine journal.

[38]  H. Tucker,et al.  Regulation of growth hormone-releasing hormone and somatostatin from perifused, bovine hypothalamic slices. II. Dopamine receptor regulation. , 1997, Domestic animal endocrinology.

[39]  E. Pellegrini,et al.  Central Administration of a Growth Hormone (GH) Receptor mRNA Antisense Increases GH Pulsatility and Decreases Hypothalamic Somatostatin Expression in Rats , 1996, The Journal of Neuroscience.

[40]  J. Veldhuis,et al.  An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. , 1996, The Journal of clinical endocrinology and metabolism.

[41]  J. Kamegai,et al.  Growth hormone receptor gene is expressed in neuropeptide Y neurons in hypothalamic arcuate nucleus of rats. , 1996, Endocrinology.

[42]  R. Steiner,et al.  Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. , 1996, Endocrinology.

[43]  R. Steiner,et al.  Identification of target cells for growth hormone's action in the arcuate nucleus. , 1995, The American journal of physiology.

[44]  J. Bertherat,et al.  Neuroendocrine regulation of growth hormone. , 1995, European journal of endocrinology.

[45]  A. Barkan,et al.  Acromegaly , 1994, Drugs.

[46]  M. Arosio,et al.  Differential transduction of dopamine signal in different subtypes of human growth hormone-secreting adenomas. , 1994, The Journal of clinical endocrinology and metabolism.

[47]  D. Cocchi,et al.  Feedback effects of growth hormone on growth hormone-releasing hormone and somatostatin are not evident in aged rats , 1993, Neurobiology of Aging.

[48]  J. Bertherat,et al.  Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat. , 1993, The Journal of clinical investigation.

[49]  L. Donahue,et al.  Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4. , 1993, The Journal of endocrinology.

[50]  M. Aubert,et al.  Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. , 1993, Endocrinology.

[51]  K.,et al.  Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat brain and its colocalization in hypothalamic somatostatin neurons. , 1992, Endocrinology.

[52]  C. Llorens-Cortes,et al.  6‐Hydroxydopamine Lesions of the Locus Coeruleus Induce a Paradoxical Increase in Growth Hormone Secretion in Male Rats , 1992, Journal of neuroendocrinology.

[53]  I. Nagatsu,et al.  Do some tyrosine hydroxylase-immunoreactive neurons in the human ventrolateral arcuate nucleus and globus pallidus produce only l-DOPA? , 1991, Neuroscience Letters.

[54]  P. Chomczyński,et al.  Feedback regulation of growth hormone (GH)-releasing hormone gene expression by GH in rat hypothalamus. , 1988, Molecular endocrinology.

[55]  T. Hökfelt,et al.  Do tyrosine hydroxylase-immunoreactive neurons in the ventrolateral arcuate nucleus produce dopamine or only L-dopa? , 1988, Journal of chemical neuroanatomy.

[56]  S. Melmed,et al.  Insulin-like growth factor I action on rat anterior pituitary cells: effects of intracellular messengers on growth hormone secretion and messenger ribonucleic acid levels. , 1987, Endocrinology.

[57]  M. Vance,et al.  Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man. , 1987, The Journal of clinical endocrinology and metabolism.

[58]  M. Ackenheil,et al.  Effect of clonidine on growth hormone release in psychiatric patients and controls , 1980, Psychiatry Research.

[59]  Z. Laron,et al.  ORAL CLONIDINE AS A GROWTH HORMONE STIMULATION TEST , 1979, The Lancet.

[60]  S. Lal,et al.  Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. , 1975, The Journal of clinical endocrinology and metabolism.